Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Presentation, Management and Outcomes of COVID-19 Patients with Sickle Cell Disease

Nwabundo Anusim, MBBS, Ruby Gupta, MD, Hycienth O Ahaneku, MD MPH, PhD, Candace Franklin, DO, Savitha Balaraman, MD, Marianne Terese Huben, DO, Ishmael Jaiyesimi, DO, MS

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-138739

Published: 2020

Journal Articles

Increasing Doses of Anticoagulation Are Associated with Improved Survival in Hospitalized COVID-19 Patients

Filip Ionescu, MD, Girish B Nair, MD MS, FACP, Ioana Petrescu, MD, Anish S Konde, MD, Markie Sue Zimmer, MD, Nwabundo Anusim, MBBS, Vishal Jindal, MD, Susanna Gaikazian, MD, Joseph Anderson, MD, Michael Stender, MD, Marianne Terese Huben, DO, Ishmael Jaiyesimi, DO, MS

Blood (2020) 136 (Supplement 1): 22.

https://doi.org/10.1182/blood-2020-134835

Published: 2020

Journal Articles

Outcomes in Heparin-Induced Thrombocytopenia Managed with Direct Oral Anticoagulants

Nwabundo Anusim, MD, Filip Ionescu, MD, Anish S Konde, MD, Vishal Jindal, MD, Ruby Gupta, MD, Marianne Terese Huben, DO, Susanna Gaikazian, MD, Ishmael Jaiyesimi, DO, MS

Blood (2019) 134 (Supplement_1): 4975.

https://doi.org/10.1182/blood-2019-129485

Published: 2019

Journal Articles

Clinical Outcome Following Reinstitution of Anticoagulation after Major Gastrointestinal Bleed: A Single Institutional Analysis

Daniel E Ezekwudo, MD, Susanna Gaikazian, MD, Nwabundo Anusim, MD MPH, Anish S Konde, MD, Dana Zakalik, MD, Marianne Terese Huben, DO, Michael Stender, MD, Joseph Anderson, MD, Ishmael Jaiyesimi, DO, MS

Blood (2018) 132 (Supplement 1): 1244.

https://doi.org/10.1182/blood-2018-99-116197

Published: 2018

Journal Articles

Analysis of Genomic Aberrations and Its Impact on Survival in Patients with Chronic Lymphocytic Leukemia (CLL) at the William Beaumont Hospital Cancer Center

Foluso Nelson Ogunleye, MD, Mohammed Ibrahim, MD, Leann Michelle Blankenship, MD, Siddhartha Yadav, MD, Tolulope Ifabiyi, Vonda Douglas, MD, Mark Micale, PhD, Elisa Quiroz, MD, Susanna S Gaikazian, MD, Michael Stender, MD, Marianne Terese Huben, DO, Joseph Anderson, MD, Ishmael Jaiyesimi, DO

Blood (2016) 128 (22): 5580.

https://doi.org/10.1182/blood.V128.22.5580.5580

Published: 2016

NARROW

Presentation, Management and Outcomes of COVID-19 Patients with Sickle Cell Disease

Increasing Doses of Anticoagulation Are Associated with Improved Survival in Hospitalized COVID-19 Patients

Outcomes in Heparin-Induced Thrombocytopenia Managed with Direct Oral Anticoagulants

Clinical Outcome Following Reinstitution of Anticoagulation after Major Gastrointestinal Bleed: A Single Institutional Analysis

Analysis of Genomic Aberrations and Its Impact on Survival in Patients with Chronic Lymphocytic Leukemia (CLL) at the William Beaumont Hospital Cancer Center

Email alerts

ASH Publications

American Society of Hematology

Presentation, Management and Outcomes of COVID-19 Patients with Sickle Cell Disease

Increasing Doses of Anticoagulation Are Associated with Improved Survival in Hospitalized COVID-19 Patients

Outcomes in Heparin-Induced Thrombocytopenia Managed with Direct Oral Anticoagulants

Clinical Outcome Following Reinstitution of Anticoagulation after Major Gastrointestinal Bleed: A Single Institutional Analysis

Analysis of Genomic Aberrations and Its Impact on Survival in Patients with Chronic Lymphocytic Leukemia (CLL) at the William Beaumont Hospital Cancer Center

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only